Physicians' Academy for Cardiovascular Education

Emerging therapies to lower LDL-cholesterol

Prof. Erik Stroes, MD

10' education - May 8, 2014

Prof. Dr. Erik SG Stroes
Chair Department of Vascular Medicine
Academic Medical Center Amsterdam, The Netherlands


Prof. Erik Stroes describes novel therapeutic modalities to lower LDL-cholesterol by other means than statin-induced lowering, either by improving the clearance of LDL-c by inhibiting PCSK9, or by decreasing the production of LDL-c by ApoB antisense or inhibiting MTP. He discusses different mechanisms and presents recent trial results of investigational drugs.
 

Educational objectives

After watching this e-learning, you will know more about:

  • alternative options to lower LDL-cholesterol beyond statin therapy
  • the drugs in development and their mechanism of action
  • recent study results on the efficacy and safety of PCSK9-antibody treatment, ApoB antisense therapy and MTP-inhibitor treatment.

  
   

Start video

Share this page with your colleagues and friends: